Get started
Author

Hédia Brixi

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease
2013 · Laurent Beaugerie, Magali Svrcek, et al. · Gastroenterology · 371
PDF
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study
2017 · Yoram Bouhnik, Franck Carbonnel, et al. · Gut · 333
PDF
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease
2018 · Geert D’Haens, Severine Vermeire, et al. · Gastroenterology · 310
Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents
2015 · Pauline Wils, Yoram Bouhnik, et al. · Clinical Gastroenterology and Hepatology · 175
PDF
Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
2017 · Driffa Moussata, Matthieu Allez, et al. · Gut · 172
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
2015 · Franck Carbonnel, Jean Frédéric Colombel, et al. · Gastroenterology · 143
PDF
Updating the management of patients with rectal neuroendocrine tumors
2013 · Louis de Mestier, Hedia Brixi, et al. · Endoscopy · 113
Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience
2018 · P. Wils, Y. Bouhnik, et al. · Alimentary Pharmacology & Therapeutics · 99
Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art
2013 · Louis de Mestier, Clarisse Dromain, et al. · Endocrine Related Cancer · 89
PDF
Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study
2014 · Marie Tauber, Sébastien Buche, et al. · Journal of the American Academy of Dermatology · 82
PDF
Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery
2015 · Sophie Lardière-Deguelte, Louis de Mestier, et al. · Neuroendocrinology · 80
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
2018 · Gauthier Pellet, Carmen Stefanescu, et al. · Clinical Gastroenterology and Hepatology · 79
Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study
2020 · Pauline Wils, Philippe Seksik, et al. · Alimentary Pharmacology & Therapeutics · 76
Updating the Surgical Management of Peritoneal Carcinomatosis in Patients with Neuroendocrine Tumors
2015 · Louis de Mestier, Sophie Lardière-Deguelte, et al. · Neuroendocrinology · 57
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
2019 · Louis de Mestier, Thomas Walter, et al. · Neuroendocrinology · 52
Metachronous Hormonal Syndromes in Patients With Pancreatic Neuroendocrine Tumors
2015 · Louis de Mestier, Olivia Hentic, et al. · Annals of Internal Medicine · 52
Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up
2015 · Agnès Ruskoné-Fourmestraux, Tamara Matysiak-Budnik, et al. · Radiotherapy and Oncology · 50
SALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction
2012 · Guillemette Laval, Hubert Rousselot, et al. · Bulletin du Cancer · 44
Impact of Liver and Whole-Body Diffusion-Weighted MRI for Neuroendocrine Tumors on Patient Management: A Pilot Study
2016 · Frederick Moryoussef, Louis de Mestier, et al. · Neuroendocrinology · 43
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
2022 · Laurent Peyrin-Biroulet, Jean-François Rahier, et al. · Clinical Gastroenterology and Hepatology · 42
PDF
The IBD-disk Is a Reliable Tool to Assess the Daily-life Burden of Patients with Inflammatory Bowel Disease
2020 · Sara Tadbiri, Maria Nachury, et al. · Journal of Crohn s and Colitis · 35
PDF
Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
2018 · Pierre Baillet, Guillaume Cadiot, et al. · World Journal of Gastroenterology · 35
PDF
Sunitinib achieved fast and sustained control of VIPoma symptoms
2014 · Louis de Mestier, Thomas Walter, et al. · European Journal of Endocrinology · 31
Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy
2016 · Florian Poullenot, Philippe Seksik, et al. · Inflammatory Bowel Diseases · 30
External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab
2021 · Celine Konecki, Catherine Feliu, et al. · Pharmaceutics · 27
PDF
Works count: 88
Citation count: 3,034
H-index: 26
I10-index: 42
Year
Topic
Type